Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Clinical insights
Key research benefits
A dual-pathway growth hormone secretagogue blend combining a GHRH analog with a ghrelin-mimetic for a synergistic GH pulse.
- GH increased 2–10x and IGF-1 1.5–3x above baseline in placebo-controlled human trials of the CJC-1295 component.
- Ipamorelin triggers GH release without raising cortisol, prolactin, or ACTH — even at 200x its effective dose.
- Improved sleep quality is the most consistently reported first benefit, typically within 1–2 weeks.
Research backing
Teichman et al., J Clin Endocrinol Metab 2006 (CJC-1295 trial); Raun et al., Eur J Endocrinol 1998 (ipamorelin selectivity); Bowers et al., 1990 (GHRH+ghrelin synergy, n=18). No published trial has tested this exact blend for body composition outcomes.
Research Grade Formula
CJC1295 / Ipamorelin
Muscle Growth & Hormone Optimization
GH Stack · 5mg / 5mg
$115
Express Shipping $20 — Australia only
- Third-party tested
- Non-GMO
- GMP certified
How to use
Follow research handling and reconstitution guidance for this compound. Always use appropriate lab technique and sterile materials.
Research Dosage ProtocolWhat's inside
This dual-peptide research vial pairs CJC-1295 with Ipamorelin for growth-hormone axis laboratory work. Both sequences are supplied as a combined lyophilized solid for controlled reconstitution.
Technical overview
- Contents: CJC-1295 / Ipamorelin GH research stack (5 mg / 5 mg class)
- CJC-1295: GHRH-analogue peptide for endocrine pathway studies
- Ipamorelin: Selective ghrelin-receptor agonist research peptide
- Purity: ≥99% with analytical verification per lot
- Appearance: White to off-white freeze-dried powder
- Storage: Dry and cool before mixing; refrigerate after reconstitution
Reconstitute with bacteriostatic water at room temperature. For laboratory research and educational use only — not for human consumption.
Customer reviews
4.9
Based on 312 reviews
